Osaic Holdings
SNDX icon

Osaic Holdings’s Syndax Pharmaceuticals SNDX Stock Holding History

Osaic Holdings’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.4K Buy
2,992
+732
+32% +$15.2K ﹤0.01% 5276
2026
Q1 		$52.8K Sell
2,260
-352
-13% -$7.65K ﹤0.01% 5172
2025
Q4 		$54.9K Sell
2,612
-2
-0.1% -$35 ﹤0.01% 5166
2025
Q3 		$40.6K Buy
2,614
+731
+39% +$9.57K ﹤0.01% 5451
2025
Q2 		$17.6K Sell
1,883
-523
-22% -$5.76K ﹤0.01% 5811
2025
Q1 		$29.6K Buy
2,406
+500
+26% +$7.05K ﹤0.01% 5087
2024
Q4 		$25.2K Sell
1,906
-1,954
-51% -$33.4K ﹤0.01% 5184
2024
Q3 		$74.3K Buy
3,860
+316
+9% +$6.53K ﹤0.01% 4437
2024
Q2 		$72.8K Buy
3,544
+852
+32% +$17.8K ﹤0.01% 4381
2024
Q1 		$64.1K Buy
2,692
+978
+57% +$21.8K ﹤0.01% 4557
2023
Q4 		$37K Sell
1,714
-186
-10% -$2.86K ﹤0.01% 5094
2023
Q3 		$27.6K Buy
1,900
+200
+12% +$3.78K ﹤0.01% 5375
2023
Q2 		$35.6K Buy
1,700
+262
+18% +$5.46K ﹤0.01% 5167
2023
Q1 		$30.4K Buy
1,438
+13
+0.9% +$323 ﹤0.01% 5310
2022
Q4 		$36.2K Buy
1,425
+150
+12% +$3.5K ﹤0.01% 5165
2022
Q3 		$31K Hold
1,275
– – ﹤0.01% 5281
2022
Q2 		$24K Buy
1,275
+25
+2% +$416 ﹤0.01% 5494
2022
Q1 		$22K Buy
1,250
+1,000
+400% +$16.8K ﹤0.01% 5635
2021
Q4 		$5K Buy
+250
New +$4.62K ﹤0.01% 6655
2020
Q2 		– Sell
-2,000
Closed -$22K – 6306
2020
Q1 		$22K Buy
+2,000
New +$18.8K ﹤0.01% 4574

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Osaic Holdings's SNDX Position: Q2 2026 in Review

Osaic Holdings increased its Syndax Pharmaceuticals (SNDX) stake by 32% in Q2 2026, buying an estimated $15.2K and bringing the position to 2,992 shares worth $65.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5276.

Osaic Holdings first reported a position in SNDX in Q1 2020 and has held it in 20 quarters since. The position peaked at $74.3K in Q3 2024. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Osaic Holdings held 2,992 shares of Syndax Pharmaceuticals worth $65.4K as of Q2 2026.
  • Osaic Holdings bought 732 Syndax Pharmaceuticals shares in Q2 2026, an estimated $15.2K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5276 holding.
  • Osaic Holdings first reported a position in Syndax Pharmaceuticals in Q1 2020 and has held it in 20 quarters since.
  • Osaic Holdings's Syndax Pharmaceuticals position peaked at $74.3K in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.